Skip to content

Renal and Cardiac Risk Factors of AKI After Liver Transplantation

Renal Resistive Index and Myocardial Performance Index for Early Prediction of Acute Kidney Injury After Living Donor Liver Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05666232
Enrollment
105
Registered
2022-12-27
Start date
2023-01-31
Completion date
2024-04-30
Last updated
2022-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Acute Renal Injury, Liver Transplant; Complications

Keywords

2-D Echocardiography, Two-Dimensional Echocardiography, renal resistive index, myocardial performance index, diagnostie test accuracy, sensitivity and specificity

Brief summary

Background: Liver transplantation (LT) is an extensive operation with various factors contributing to the development of acute kidney injury in the perioperative period. Early diagnosis of AKI can improve clinical outcomes in LT recipients. Renal resistive index is measured in renal arteries and high resistive values are associated with more adverse cardiovascular events and renal failure progression. Myocardial performance index reflects overall cardiac function rather than systolic or diastolic function alone. Aim of the study: to investigate whether combined doppler renal resistive index and myocardial performance index could predict early postoperative acute kidney injury in living donor liver transplant recipients. Study design: a prospective observational study that will be conducted at Liver Transplantation Unit at Mansoura University on 105 consecutive living donor liver transplant recipients. Methods: Renal resistive index (assessed by transabdominal ultrasound) and myocardial performance index (assessed by transthoracic echocardiography) will be measured just before operation, on termination of operation and then daily in the intensive care unit for 7 days. Patients will be observed for development of acute kidney injury.

Detailed description

This study aims to investigate whether combined doppler renal resistive index (RRI) assessed by transabdominal sonography and myocardial performance index (MPI) assessed by transthoracic echocardiography could predict early postoperative acute kidney injury in living donor liver transplant recipients. The primary outcome is the predictive value of renal resistive index and myocardial performance index for the onset of early post living donor liver transplant acute kidney injury. This prospective observational study will be conducted at Liver Transplantation Unit at Mansoura University from November 2022 till fulfillment of sample size after obtaining approval from Institutional Review Board (IRB). One hundred and five consecutive LDLT recipients will participate in this study after obtaining informed consents. They will be observed for the development of early postoperative acute kidney injury.

Interventions

DIAGNOSTIC_TESTrenal resistive index and myocardial performance index

Transthoracic echocardiography and transabdominal ultrasonography will be performed before induction of anesthesia, after termination of operation and before transmission to ICU and then daily for the early seven postoperative days. RRI = (peak systolic velocity - end diastolic velocity) ∕ peak systolic velocity: Then, we will obtain the mean RRI from the above three measurements. We will consider RRI ≥0.7 as abnormal and define it as subclinical AKI. Myocardial performance index (using tissue doppler) = (isovolumetric contraction time + isovolumetric relaxation time) / ejection time. We will consider MPI ≥0.4 as abnormal and define it as subclinical LV dysfunction.

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* patients undergoing right-lobe living-donor liver transplantation

Exclusion criteria

* preoperative renal impairment (GFR \< 60 ml/min/1.73 m2) * known renal artery stenosis * patient who underwent previous nephrectomy * ischemic heart disease (patient who takes anti-ischemic measures as prescribed by a consultant cardiologist) * Patient with arrthymia or who develop persistent intraoperative arrythmia

Design outcomes

Primary

MeasureTime frameDescription
early acute kidney injury (AKI)in the early 48 postoperative hoursinternational Club of Ascites' revised classification of AKI in cirrhotic patients as a 0.3 mg/kg increase in serum creatinine

Secondary

MeasureTime frameDescription
late AKIwithin 7 daysInternational Club of Ascites' revised classification of AKI in cirrhotic patients as a 0.3 mg/kg increase in serum creatinine or \>= 50% increase in the basal serum creatinine
length of ICU stay3 months after transplantduration of ICU stay (days) in survived patients
stage of AKIin the early 48 postoperative hoursStage (1): serum creatinine increase 1.5- 1.9 times base line; or serum creatinine increase more than 0.3mg/dl. Stage (2): serum creat. Increase 2-2.9 times baseline. Stage (3): serum creat. Increase 3 times baseline ; or s.creat increase to 4mg/dl; or initiation of renal replacement therapy.
three-month mortality3 months after transplantationall-cause mortality
delayed renal function3 months after transplantationserum creatinine
length of hospital stay3 months after transplantduration of ICU stay (days) in survived patients

Contacts

Primary ContactAhmed Ali El-din, MSc
ahmedalieldin2000@gmail.com1288045390
Backup ContactMoataz M Emara, MD, EDAIC
mm.emara@mans.edu.eg1064048848

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026